The DOI matches its Crossref record; 306 of the 306 references it cites were found in a registry or an index.
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood-brain barrier. Nanotechnological treatment methods, which involve the design, characterization, production, and application of nanoscale drug delivery systems, have been employed to optimize therapeutics. These nanotechnologies include polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, microemulsion, nanoemulsion, and liquid crystals. Each of these are promising tools for the delivery of therapeutic devices to the brain via various routes of administration, particularly the intranasal route. The objective of this study is to present a systematic review of nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · Focus · doi:10.1176/appi.focus.11.1.96 · Cited by 2,621
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Nanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2012) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,778
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“An in vivo study with an animal model of AD also showed that chelating agents could solubilize amyloid plaques.(64) According to the cholinergic hypothesis, the dysfunction of the cholinergic system is sufficient to produce a memory deficit in animal models that is similar to AD.”
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Touitou, E., Dayan, N., Bergelson, L., Godin, B., & Eliaz, M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00222-9 · Cited by 1,345
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“In AD, the reactive astrocytes are increased, 75,76 and there is a high expression of PA2.”
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
The basics and underlying mechanisms of mucoadhesion
SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes
Olson, F., Hunt, C. A., Szoka, F. C., Vail, W. J., & Papahadjopoulos, D. (1979) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(79)90085-3 · Cited by 1,126
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Clark, C. M. (2011) · JAMA · doi:10.1001/jama.2010.2008 · Cited by 1,117
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Mehnert, W., & Mäder, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.021 · Cited by 981
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Novel applications of liposomes
Lasic, D. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01220-7 · Cited by 867
Cevc, G., & Blume, G. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90154-e · Cited by 850
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00009 · Cited by 771
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762
Mucoadhesive drug delivery systems
Donnelly, R., Shaikh, R., Raj Singh, T., Garland, M., & Woolfson, A. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.76478 · Cited by 740
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Parsons, C. G., Stöffler, A., & Danysz, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.013 · Cited by 707
Bilati, U., Allémann, E., & Doelker, E. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.09.011 · Cited by 686
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
Killiany, R. J., Gomez-Isla, T., Moss, M., Kikinis, R., Sandor, T., Jolesz, F., Tanzi, R., Jones, K., Hyman, B. T., & Albert, M. S. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<430::aid-ana5>3.0.co;2-i · Cited by 664
The prevalence and causes of dementia in people under the age of 65 years
Harvey, R. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1206 · Cited by 649
18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., Hasselbalch, S., Law, I., Andersen, A., Korner, A., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22068 · Cited by 646
Nanoemulsions: formation, structure, and physical properties
Mason, T. G., Wilking, J. N., Meleson, K., Chang, C. B., & Graves, S. M. (2007) · Journal of Physics: Condensed Matter · doi:10.1088/0953-8984/19/7/079001 · Cited by 626
Cubic phase gels as drug delivery systems
Shah, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00108-9 · Cited by 625
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
MRI measures of entorhinal cortex vs hippocampus in preclinical AD
Killiany, R. J., Hyman, B. T., Gomez-Isla, T., Moss, M. B., Kikinis, R., Jolesz, F., Tanzi, R., Jones, K., & Albert, M. S. (2002) · Neurology · doi:10.1212/wnl.58.8.1188 · Cited by 567
When poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567
Berendsen, A. A. M., Kang, J. H., van de Rest, O., Jankovic, N., Kampman, E., Kiefte-de Jong, J. C., Franco, O. H., Ikram, M. A., Pikhart, H., Nilsson, L. M., et al. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000464269 · Cited by 562
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000244749.20056.d4 · Cited by 518
Surfactant self-assembly objects as novel drug delivery vehicles
Drummond, C. J., & Fong, C. (1999) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00020-0 · Cited by 515
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution
Mainardes, R. M., & Evangelista, R. C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.027 · Cited by 494
Nanoparticles for Brain Drug Delivery
Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 489
Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion
Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., & Bush, A. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23223 · Cited by 482
Inflammatory Neurodegeneration Mediated by Nitric Oxide, Glutamate, and Mitochondria
Brown, G. C., & Bal-Price, A. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:325 · Cited by 461
Getting into the Brain: Approaches to Enhance Brain Drug Delivery
Patel, M. M., Goyal, B. R., Bhadada, S. V., Bhatt, J. S., & Amin, A. F. (2009) · CNS Drugs · doi:10.2165/0023210-200923010-00003 · Cited by 461
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
New Acetylcholinesterase Inhibitors for Alzheimer's Disease
Mehta, M., Adem, A., & Sabbagh, M. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/728983 · Cited by 436
Rossor, M. N., Emson, P. C., Mountjoy, C. Q., Roth, M., & Iversen, L. L. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90177-9 · Cited by 433
Advanced drug delivery systems: Nanotechnology of health design A review
Safari, J., & Zarnegar, Z. (2014) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2012.12.009 · Cited by 429
Strategy for effective brain drug delivery
Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.003 · Cited by 415
Murakami, H., Kobayashi, M., Takeuchi, H., & Kawashima, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00187-8 · Cited by 405
Bioadhesive drug delivery systems
Nielsen, L. S., Schubert, L., & Hansen, J. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10004-5 · Cited by 403
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Lajoie, J. M., & Shusta, E. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124852 · Cited by 399
Goldman, J. S., Hahn, S. E., Catania, J. W., Larusse-Eckert, S., Butson, M. B., Rumbaugh, M., Strecker, M. N., Roberts, J. S., Burke, W., Mayeux, R., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31821d69b8 · Cited by 393
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting
Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.013 · Cited by 379
Xia, P., Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2488-10.2010 · Cited by 379
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374
Characterization and potential applications of nanostructured aqueous dispersions
Yaghmur, A., & Glatter, O. (2009) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2008.07.007 · Cited by 373
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors
Jann, M. W., Shirley, K. L., & Small, G. W. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00003 · Cited by 365
Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Interleukin-1, neuroinflammation, and Alzheimer's disease
Mrak, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00287-1 · Cited by 356
Provisional Diagnostic Criteria for Depression of Alzheimer Disease
Olin, J. T., Schneider, L. S., Katz, I. R., Meyers, B. S., Alexopoulos, G. S., Breitner, J. C., Bruce, M. L., Caine, E. D., Cummings, J. L., Devanand, D. P., et al. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200203000-00003 · Cited by 349
Finder, V. H., & Glockshuber, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000100355 · Cited by 348
Mucoadhesive drug delivery systems
Carvalho, F. C., Bruschi, M. L., Evangelista, R. C., & Gremião, M. P. D. (2010) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502010000100002 · Cited by 343
Quantitative analysis of drug delivery to the brain via nasal route
Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 337
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Johnstone, M., Gearing, A. J. H., & Miller, K. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00226-4 · Cited by 313
Provisional Diagnostic Criteria for Depression of Alzheimer Disease
Olin, J. T. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.2.125 · Cited by 312
The Metal Theory of Alzheimer's Disease
Bush, A. I. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129011 · Cited by 305
Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.
Guterres, S. S., Alves, M. P., & Pohlmann, A. R. (2007) · PubMed · Cited by 302
Surfactants and Polymers in Drug Delivery
(2002) · CRC Press eBooks · doi:10.1201/9780824743758 · Cited by 299
Gao, X., Tao, W., Lu, W., Zhang, Q., Zhang, Y., Jiang, X., & Fu, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.038 · Cited by 295
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Brambilla, D., Le Droumaguet, B., Nicolas, J., Hashemi, S. H., Wu, L.-P., Moghimi, S. M., Couvreur, P., & Andrieux, K. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.03.008 · Cited by 294
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Li, C., Zhao, R., Gao, K., Wei, Z., Yaoyao Yin, M., Ting Lau, L., Chui, D., & Cheung Hoi Yu, A. (2011) · Current Alzheimer Research · doi:10.2174/156720511794604543 · Cited by 289
(2001) · PubMed Central · Cited by 289
Agarwal, R., Katare, O. P., & Vyas, S. P. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00810-9 · Cited by 288
Spray-drying of solid lipid nanoparticles (SLNTM)
Freitas, C., & Müller, R. H. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00172-0 · Cited by 282
WILSON, B., SAMANTA, M., SANTHI, K., KUMAR, K., PARAMAKRISHNAN, N., & SURESH, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.009 · Cited by 278
Pre-Clinical Detection of Alzheimer's Disease Using FDG-PET, with or without Amyloid Imaging
Mosconi, L., Berti, V., Glodzik, L., Pupi, A., De Santi, S., & de Leon, M. J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091504 · Cited by 277
Sun, J., Bi, C., Chan, H. M., Sun, S., Zhang, Q., & Zheng, Y. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.06.032 · Cited by 277
Malouf, R., & Grimley Evans, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004514.pub2 · Cited by 277
Das, S., Ng, W. K., Kanaujia, P., Kim, S., & Tan, R. B. H. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.07.036 · Cited by 274
Johnson, K. A., Sperling, R. A., Gidicsin, C. M., Carmasin, J. S., Maye, J. E., Coleman, R. E., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.10.007 · Cited by 270
Gao, K., & Jiang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.040 · Cited by 269
Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent
Kaasgaard, T., & Drummond, C. J. (2006) · Physical Chemistry Chemical Physics · doi:10.1039/b609510k · Cited by 268
Gratton, S. E. A., Pohlhaus, P. D., Lee, J., Guo, J., Cho, M. J., & DeSimone, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.027 · Cited by 266
Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Zhang, C., Wan, X., Zheng, X., Shao, X., Liu, Q., Zhang, Q., & Qian, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.063 · Cited by 262
Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery
Graff, C. L., & Pollack, G. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20318 · Cited by 260
Berger, N., Sachse, A., Bender, J., Schubert, R., & Brandl, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00721-9 · Cited by 258
Lipton, S. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585846 · Cited by 256
Vila, A., Gill, H., McCallion, O., & Alonso, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.026 · Cited by 249
Yang, Z.-Z., Zhang, Y.-Q., Wang, Z.-Z., Wu, K., Lou, J.-N., & Qi, X.-R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.009 · Cited by 248
Lipophilic drug derivatives in liposomes
Gulati, M., Grover, M., Singh, S., & Singh, M. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00006-4 · Cited by 245
Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Joshi, S. A., Chavhan, S. S., & Sawant, K. K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.007 · Cited by 235
The Diagnosis of Dementia With Single Photon Emission Computed Tomography
Jagust, W. J., Budinger, T. F., & Reed, B. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520150014011 · Cited by 234
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Mourtas, S., Canovi, M., Zona, C., Aurilia, D., Niarakis, A., La Ferla, B., Salmona, M., Nicotra, F., Gobbi, M., & Antimisiaris, S. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.027 · Cited by 230
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier
Barbu, E., Molnàr, É., Tsibouklis, J., & Górecki, D. C. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902939143 · Cited by 229
Bioadhesion of hydrated chitosans: An in vitro and in vivo study
Henriksen, I. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04776-x · Cited by 226
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma
Zhang, B., Sun, X., Mei, H., Wang, Y., Liao, Z., Chen, J., Zhang, Q., Hu, Y., Pang, Z., & Jiang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.039 · Cited by 225
Drug delivery in biotechnology: present and future
Orive, G., Hernández, R. M., Gascón, A. R., Domı́nguez-Gil, A., & Pedraz, J. L. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.007 · Cited by 223
Kakkar, V., Muppu, S. K., Chopra, K., & Kaur, I. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.02.005 · Cited by 222
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
Sun, W., Xie, C., Wang, H., & Hu, Y. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.087 · Cited by 215
Kumar, V. V., Chandrasekar, D., Ramakrishna, S., Kishan, V., Rao, Y. M., & Diwan, P. V. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.004 · Cited by 213
Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease
Marshall, G. A., Monserratt, L., Harwood, D., Mandelkern, M., Cummings, J. L., & Sultzer, D. L. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.1015 · Cited by 212
Drug transport to brain with targeted liposomes
Schnyder, A., & Huwyler, J. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.99 · Cited by 210
Wang, W., Zhu, Xie, Li, Xiao, Li, Liu, Wang, S., & Cui, D. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30428 · Cited by 209
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204
Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?
Mathison, S., Nagilla, R., & Kompella, U. B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997870 · Cited by 200
Resveratrol loaded liposomes produced by different techniques
Isailović, B. D., Kostić, I. T., Zvonar, A., Đorđević, V. B., Gašperlin, M., Nedović, V. A., & Bugarski, B. M. (2013) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2013.03.006 · Cited by 197
Zhang, C., Chen, J., Feng, C., Shao, X., Liu, Q., Zhang, Q., Pang, Z., & Jiang, X. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.049 · Cited by 197
Non-destructive methods of characterization of risperidone solid lipid nanoparticles
Rahman, Z., Zidan, A. S., & Khan, M. A. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.003 · Cited by 197
CNS Drug Delivery Systems: Novel Approaches
Pathan, S., Iqbal, Z., Zaidi, S., Talegaonkar, S., Vohra, D., Jain, G., Azeem, A., Jain, N., Lalani, J., Khar, R., et al. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109787158355 · Cited by 193
Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs
Parveen, S., & Sahoo, S. K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00002 · Cited by 189
Pharmacodynamics of Memantine: An Update
Parsons, C., Rammes, G., & Danysz, W. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769671 · Cited by 183
Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Henke, H., & Lang, W. (1983) · Brain Research · doi:10.1016/0006-8993(83)90880-6 · Cited by 176
The size of solid lipid nanoparticles: An interpretation from experimental design
Vitorino, C., Carvalho, F. A., Almeida, A. J., Sousa, J. J., & Pais, A. A. C. C. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.12.024 · Cited by 176
Bondì, M. L., Craparo, E. F., Giammona, G., & Drago, F. (2010) · Nanomedicine · doi:10.2217/nnm.09.67 · Cited by 175
Pillay, V., Murugan, K., Choonara, Y. E., Kumar, P., Bijukumar, D., & du Toit, L. C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75615 · Cited by 175
Yusuf, M., Khan, M., Khan, R. A., & Ahmed, B. (2013) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.747529 · Cited by 171
Luxenberg, J. S., Haxby, J. V., Creasey, H., Sundaram, M., & Rapoport, S. I. (1987) · Neurology · doi:10.1212/wnl.37.7.1135 · Cited by 165
Srinivasan, M., & Lahiri, D. K. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.989834 · Cited by 164
Muller, R. H., Radtke, M., & Wissing, S. A. (2003) · ChemInform · doi:10.1002/chin.200335261 · Cited by 164
Aprahamian, M., Michel, C., Humbert, W., Devissaguet, J. P., & Damge, C. (1987) · Biology of the Cell · doi:10.1111/j.1768-322x.1987.tb00571.x · Cited by 163
Gutzmann, H., & Hadler, D. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_30 · Cited by 162
Soininen, H., Kosunen, O., Helisalmi, S., Mannermaa, A., Paljärvi, L., Talasniemi, S., Ryynänen, M., & Riekkinen, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11343-6 · Cited by 162
A study of rivastigmine liposomes for delivery into the brain through intranasal route
Arumugam, K., Subramanian, G., Mallayasamy, S., Averineni, R., Reddy, M., & Udupa, N. (2008) · Acta Pharmaceutica · doi:10.2478/v10007-008-0014-3 · Cited by 162
Chu, K. S., Hasan, W., Rawal, S., Walsh, M. D., Enlow, E. M., Luft, J. C., Bridges, A. S., Kuijer, J. L., Napier, M. E., Zamboni, W. C., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.008 · Cited by 162
Pawar, D., Mangal, S., Goswami, R., & Jaganathan, K. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.06.017 · Cited by 161
Kulkarni, P. V., Roney, C. A., Antich, P. P., Bonte, F. J., Raghu, A. V., & Aminabhavi, T. M. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.59 · Cited by 159
Cacabelos, R., Takeda, M., & Winblad, B. G. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199901)14:1<3::aid-gps897>3.0.co;2-7 · Cited by 157
Lü, W., Tan, Y.-Z., Hu, K., & Jiang, X. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.043 · Cited by 156
Xie, S., Zhu, L., Dong, Z., Wang, X., Wang, Y., Li, X., & Zhou, W. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.12.014 · Cited by 156
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
Hashizume, R., Ozawa, T., Gryaznov, S. M., Bollen, A. W., Lamborn, K. R., Frey, W. H., & Deen, D. F. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-052 · Cited by 155
Gan, Y., Li, X., Chen, D., Le, C., Zhu, C., Hovgaard, L., & Yang, M. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25741 · Cited by 155
Vinpocetine for cognitive impairment and dementia
Szatmári, S., & Whitehouse, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003119 · Cited by 151
Nazem, A., & Mansoori, G. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13210 · Cited by 150
Ji, H., Tang, J., Li, M., Ren, J., Zheng, N., & Wu, L. (2014) · Drug Delivery · doi:10.3109/10717544.2014.918677 · Cited by 149
Lazar, A. N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S. G., & Duyckaerts, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.004 · Cited by 149
Wang, B.-S., Wang, H., Wei, Z.-H., Song, Y., Zhang, L., & Chen, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0189-x · Cited by 148
Alshamsan, A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.12.002 · Cited by 147
Spray freeze drying for dry powder inhalation of nanoparticles
Ali, M. E., & Lamprecht, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.009 · Cited by 143
Martins, S. M., Sarmento, B. F. C. C., Nunes, C., Lúcio, M., Reis, S., & Ferreira, D. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.011 · Cited by 142
Choi, S., Schneider, J. A., Bennett, D. A., Beach, T. G., Bedell, B. J., Zehntner, S. P., Krautkramer, M. J., Kung, H. F., Skovronsky, D., Hefti, F. F., et al. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31821300bc · Cited by 136
Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2006) · Current Drug Delivery · doi:10.2174/156720106777731019 · Cited by 136
Xin, H., Sha, X., Jiang, X., Chen, L., Law, K., Gu, J., Chen, Y., Wang, X., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.018 · Cited by 135
Pharmacological Treatment of Alzheimer Disease
Massoud, F., & Léger, G. C. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601003 · Cited by 130
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents
Cortesi, R., Esposito, E., Gambarin, S., Telloli, P., Menegatti, E., & Nastruzzi, C. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289220 · Cited by 130
Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting
Jogani, V. V., Shah, P., Mishra, P., Mishra, A. K., & Misra, A. R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318157205b · Cited by 129
Jousma, H., Talsma, H., Spies, F., Joosten, J. G. H., Junginger, H. E., & Crommelin, D. J. A. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90139-6 · Cited by 129
Predicting hydrophilic drug encapsulation inside unilamellar liposomes
Xu, X., Khan, M. A., & Burgess, D. J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.019 · Cited by 129
Wang, P., Zhang, L., Peng, H., Li, Y., Xiong, J. P., & Xu, Z. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.07.047 · Cited by 126
Memantine: targeting glutamate excitotoxicity in Alzheimer’s disease and other dementias
Molinuevo, J. L., Lladó, A., & Rami, L. (2005) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750502000206 · Cited by 125
Kuo, Y., & Liang, C.-T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.048 · Cited by 125
Arora, S. (2011) · Scientia Pharmaceutica · doi:10.3797/scipharm.1011-05 · Cited by 121
A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
Weyer, G., Babej-Dölle, R. M., Hadler, D., Hofmann, S., & Herrmann, W. M. (2008) · Neuropsychobiology · doi:10.1159/000119366 · Cited by 120 · cited 1×
“…and N -carboxymethylchitosan NPs. 29 Although the authors did not study the use of these NPs in the treatment of AD, the beneficial effects of idebenone for the treatment of AD 177,178 and its role as an antioxidant in AD progression 55,58,179–181 have been well documented in clinical trials.”
Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 120
Characterization of β-carotene nanoemulsions prepared by microfluidization technique
Jo, Y., & Kwon, Y.-J. (2013) · Food Science and Biotechnology · doi:10.1007/s10068-014-0014-7 · Cited by 120
Boudad, H., Legrand, P., Bas, G. L., Chéron, M., Duchêne, D., & Ponchel, G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00622-6 · Cited by 120
Lai, F., Fadda, A. M., & Sinico, C. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.766714 · Cited by 119
Development of a novel niosomal system for oral delivery of Ginkgo biloba extract
Jin, Y., Wen, J., Garg, S., Zhang, L., Teng, L. R., Liu, & Zhou, Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s37984 · Cited by 118
Kovačević, A. B., Müller, R. H., Savic, S. D., Vuleta, G. M., & Keck, C. M. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.12.023 · Cited by 118
Factors involved in the production of liposomes with a high-pressure homogenizer
Barnadas‐Rodríguez, R., & Sabés, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00661-x · Cited by 117
Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain
Suresh Ramnath, N. A. I. K., Pilgaonkar, V. W., & Panda, V. S. (2006) · Phytotherapy Research · doi:10.1002/ptr.1976 · Cited by 113
The Effect of Curcumin on the Stability of Aβ Dimers
Zhao, L. N., Chiu, S.-W., Benoit, J., Chew, L. Y., & Mu, Y. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp3034209 · Cited by 113
Mucoadhesive Drug Delivery Systems
Hombach, J., & Bernkop‐Schnürch, A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_9 · Cited by 110
Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers
Dong, Y., Ng, W. K., Shen, S., Kim, S., & Tan, R. B. H. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.02.013 · Cited by 110
Cited by
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Applications of nanotechnology in drug delivery to the central nervous system
Saeedi, M., Eslamifar, M., Khezri, K., & Dizaj, S. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.133 · Cited by 342
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
Metadata
- Authors
- Fonseca-Santos, B., Chorilli, M., & Palmira Daflon Gremião, M.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2015-08
- Volume
- 10
- Pages
- 4981
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W1834838125
- Cited by
- 308
- References
- 306
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.